Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.8200
-0.0373 (-4.35%)
At close: Mar 28, 2025, 4:00 PM
0.8186
-0.0014 (-0.17%)
After-hours: Mar 28, 2025, 7:55 PM EDT

Sangamo Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
57.8176.23111.3110.7118.19
Upgrade
Revenue Growth (YoY)
-67.20%58.34%0.54%-6.34%15.39%
Upgrade
Cost of Revenue
111.52230.46249.9230.82180.65
Upgrade
Gross Profit
-53.72-54.23-138.6-120.12-62.46
Upgrade
Selling, General & Admin
44.6360.0762.6863.2267.1
Upgrade
Operating Expenses
44.6360.0762.6863.2267.1
Upgrade
Operating Income
-98.35-114.29-201.28-183.34-129.55
Upgrade
Interest & Investment Income
8.88.256.435.358.78
Upgrade
Currency Exchange Gain (Loss)
-2.942.85---
Upgrade
EBT Excluding Unusual Items
-92.49-103.19-194.85-177.99-120.78
Upgrade
Merger & Restructuring Charges
-0.1-4.7---
Upgrade
Impairment of Goodwill
--38.14---
Upgrade
Gain (Loss) on Sale of Investments
0----
Upgrade
Asset Writedown
-5.52-116.88---
Upgrade
Other Unusual Items
--3--
Upgrade
Pretax Income
-98.11-262.9-191.85-177.99-120.78
Upgrade
Income Tax Expense
-0.17-5.070.430.310.35
Upgrade
Earnings From Continuing Operations
-97.94-257.83-192.28-178.3-121.12
Upgrade
Minority Interest in Earnings
---0.010.13
Upgrade
Net Income
-97.94-257.83-192.28-178.29-121
Upgrade
Net Income to Common
-97.94-257.83-192.28-178.29-121
Upgrade
Shares Outstanding (Basic)
202174154145134
Upgrade
Shares Outstanding (Diluted)
202174154145134
Upgrade
Shares Change (YoY)
15.62%13.02%6.76%7.53%19.92%
Upgrade
EPS (Basic)
-0.49-1.48-1.25-1.23-0.90
Upgrade
EPS (Diluted)
-0.49-1.48-1.25-1.23-0.90
Upgrade
Free Cash Flow
-67.41-246-243.8-256.53155.16
Upgrade
Free Cash Flow Per Share
-0.33-1.41-1.58-1.771.15
Upgrade
Gross Margin
-92.94%-30.77%-124.53%-108.51%-52.84%
Upgrade
Operating Margin
-170.15%-64.85%-180.85%-165.62%-109.61%
Upgrade
Profit Margin
-169.45%-146.30%-172.76%-161.05%-102.37%
Upgrade
Free Cash Flow Margin
-116.62%-139.59%-219.05%-231.73%131.28%
Upgrade
EBITDA
-93.24-99.23-189.17-173.9-123.87
Upgrade
EBITDA Margin
-161.32%-56.31%-169.97%-157.09%-104.80%
Upgrade
D&A For EBITDA
5.1115.0712.119.445.68
Upgrade
EBIT
-98.35-114.29-201.28-183.34-129.55
Upgrade
EBIT Margin
-170.15%-64.85%-180.85%-165.61%-109.61%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q